Related Experiment Video
Updated: Jul 25, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Original Article: MicroRNA Dysregulation in the Gastric Carcinogenesis Cascade: Can We Anticipate Its Role in
Inês Pita1, Diogo Libânio1,2, Francisca Dias3,4
1Gastroenterology Department, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.
Background:
Gastric carcinogenesis progresses from normal mucosa, atrophic/metaplastic gastritis, and dysplasia to adenocarcinoma. MicroRNAs (miRNAs) regulate DNA expression and have been implicated; however, their role is not fully established.
Aims:
The aim of this study was to characterize plasma and tissue expression of several miRNAs in gastric carcinogenesis stages.
Methods:
Single-center cross-sectional study in 64 patients: 19 controls (normal mucosa); 15 with extensive atrophic/metaplastic gastritis; and 30 with early gastric neoplasia (EGN). Seven miRNAs (miR-21, miR-146a, miR-181b, miR-370, miR-375, miR 181b, and miR-490) were quantified by real time-qPCR in peripheral blood and endoscopic biopsy samples.
Results:
We found a significant upregulation of miR-181b, miR-490, and miR-21 in the EGN mucosa (overexpression 2-14-times higher than controls). We observed a significant underexpression of miR-146a and miR-370 in atrophic/metaplastic gastritis (86 and 66% decrease, p = 0.008 and p = 0.001) and in EGN (89 and 62% reduction, p = 0.034 and p = 0.032) compared with controls. There were no differences between lesions and nonneoplastic mucosa and no dysregulation of plasma miRNAs.
Conclusion:
We found significant dysregulation of 5 miRNAs in gastric carcinogenesis, suggesting a tumor suppressor role for miR-146a and miR-370 and oncogenic potential for miR-21, miR-181, and miR-490. These changes happen diffusely in the gastric mucosa, suggesting a high-risk field defect, which may influence these patients' surveillance.
Insights
MicroRNA (miRNA) dysregulation in gastric carcinogenesis involves specific molecules. miR-146a and miR-370 may act as tumor suppressors, while miR-21, miR-181b, and miR-490 show oncogenic potential in early gastric neoplasia.
Area of Science:
- Gastroenterology and Molecular Oncology
- Biomarker Discovery
Background:
- Gastric carcinogenesis involves a progression from normal mucosa through atrophic gastritis and dysplasia to adenocarcinoma.
- MicroRNAs (miRNAs) are key regulators of gene expression and are implicated in various cancers, including gastric cancer, though their precise roles are still under investigation.
Purpose of the Study:
- To investigate and characterize the expression patterns of specific microRNAs (miRNAs) in both plasma and tissue samples across different stages of gastric carcinogenesis.
- To determine the potential role of these miRNAs as biomarkers in the progression of gastric cancer.
Main Methods:
- A single-center, cross-sectional study involving 64 patients, categorized into normal mucosa (19 controls), extensive atrophic/metaplastic gastritis (15), and early gastric neoplasia (EGN) (30).
- Quantitative real-time PCR was used to measure the expression levels of seven selected miRNAs (miR-21, miR-146a, miR-181b, miR-370, miR-375, and miR-490) in peripheral blood and endoscopic biopsy specimens.
Main Results:
- Significant upregulation of miR-181b, miR-490, and miR-21 was observed in the EGN mucosa compared to controls (2-14 times higher).
- Significant underexpression of miR-146a and miR-370 was found in both atrophic/metaplastic gastritis and EGN tissues compared to controls (66-89% reduction).
- No significant differences in miRNA expression were detected between neoplastic lesions and non-neoplastic mucosa, and plasma miRNA levels showed no significant dysregulation.
Conclusions:
- Five miRNAs (miR-21, miR-146a, miR-181b, miR-370, miR-490) exhibit significant dysregulation during gastric carcinogenesis.
- miR-146a and miR-370 may function as tumor suppressors, whereas miR-21, miR-181b, and miR-490 show potential as oncogenes in gastric cancer development.
- The diffuse changes in miRNA expression within the gastric mucosa suggest a 'field defect' that could be crucial for patient surveillance strategies.
Related Concept Videos
MicroRNAs
MicroRNAs
Gastritis II: Pathophysiology

